Adaptive Biotechnologies Corp. (ADPT)
26.89
-2.95
(-9.89%)
USD |
NASDAQ |
Oct 06, 16:00
26.96
+0.07
(+0.26%)
After-Hours: 20:00
Adaptive Biotechnologies Free Cash Flow : -24.03M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.03M |
| March 31, 2026 | -29.54M |
| December 31, 2025 | -48.94M |
| September 30, 2025 | -62.94M |
| June 30, 2025 | -82.81M |
| March 31, 2025 | -88.76M |
| December 31, 2024 | -98.88M |
| September 30, 2024 | -114.54M |
| June 30, 2024 | -136.59M |
| March 31, 2024 | -144.81M |
| December 31, 2023 | -167.02M |
| September 30, 2023 | -171.35M |
| June 30, 2023 | -169.73M |
| March 31, 2023 | -194.84M |
| Date | Value |
|---|---|
| December 31, 2022 | -200.29M |
| September 30, 2022 | -230.80M |
| June 30, 2022 | -241.03M |
| March 31, 2022 | -247.92M |
| December 31, 2021 | -254.47M |
| September 30, 2021 | -240.62M |
| June 30, 2021 | -233.92M |
| March 31, 2021 | -208.00M |
| December 31, 2020 | -168.49M |
| September 30, 2020 | -148.48M |
| June 30, 2020 | -130.68M |
| March 31, 2020 | -114.84M |
| December 31, 2019 | 194.20M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Personalis, Inc. | -100.98M |
| 10X Genomics, Inc. | 121.44M |
| Alamar Biosciences, Inc. (California) | -63.24M |
| Champions Oncology, Inc. | -6.137M |
| Medpace Holdings, Inc. | 706.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.40M |
| Cash from Investing (Quarterly) | -43.48M |
| Cash from Financing (Quarterly) | 142.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0474 |
| Free Cash Flow to Equity (Quarterly) | -209.90M |
| Free Cash Flow to Firm (Quarterly) | -4.89M |
| Free Cash Flow Yield | -0.57% |